99
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Acute lymphoblastic leukaemia cells express CCR7 but not higher amounts of IL‐10 after CD40 ligation

, , , , , , , , , , , , , & show all
Pages 695-704 | Received 18 Mar 2006, Accepted 13 Jul 2006, Published online: 08 Jul 2009

References

  • Łuczyński W., Stasiak‐Barmuta A., Krawczuk‐Rybak M., Malinowska I. Assessment of selected costimulatory, adhesion, activatory molecules and cytokines of Th1/Th2 balance in acute lymphoblastic leukaemia in children. Arch Immun Ther Exp 2005; 53: 357–63
  • Kebelmann‐Betzing C., Korner G., Badiali L., Buchwald D., Moricke A., Korte A., et al. Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor ALL. Cytokine 2001; 13: 39–50
  • Zhang X‐L., Komada Y., Chipeta J., Li Q‐S., Inaba H., Azuma E., et al. Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia. Cancer Immunol Immunother 2000; 49: 165–72
  • Wu S., Gessner R., Stackelberg Av., Kirchner R., Henze G., Seeger K. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia. Cancer 2005; 103: 1054–63
  • Cignetti A., Vallario A., Roato I., Circosta P., Allione B., Casorzo L., et al. Leukemia‐derived immature dendritic cells differentiate into functionally competent mature dendritic cells that effeciently stimulate T cell responses. J Immunol 2004; 173: 2855–65
  • D'Amico G., Bugarin M. V., Bianchi G., Pirovano G., Bonamino M., Marin V., et al. CD40 activation of BCP‐ALL cells generates IL‐10 producing, IL‐12 defective APCs that induce allogeneic T‐cell anergy. Blood 2004; 104: 744–51
  • D'Amico G., Marin V., Biondi A., Bonamino M. H. Potential use of CD40 ligand for immunotherapy of childhood B‐cell precursor acute lymphoblastic leukaemia. Best Pract Res Clin Hematol 2004; 17: 465–77
  • Mellstedt H., Choudhury A. T and B cells in B‐chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil. Cancer Immunol Immunother 2006; 55: 210–20
  • Łuczyński W., Stasiak‐Barmuta A., Iłendo E., Krawczuk‐Rybak M., Malinowska I., Mitura‐Lesiuk M., et al. CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells. Acta Biochim Pol 2006; 53: 377–82
  • Haining W. N., Cardoso A. A., Keczkemethy H. L., Fleming M., Neuber D., DeAngelo D. J., et al. Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemia. Exp Hematol 2005; 33: 286–94
  • Loskog A., Ninalga C., Totterman T. T. Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors. Cancer Immunol Immunother 2006; 55: 588–97
  • Lee J., Sait S. N., Wetzler M. Characterisation of dendritic‐like cells derived from t(9;22) acute lymphoblastic leukemia blasts. Int Immunol 2004; 16: 1377–89
  • Hoogendoorn M., Wolbers J. O., Smit W. M., Schaafsma M. R., Barge R. M. Y., Willemze R., et al. Generation of B‐cell chronic lymphocytic leukemia (B‐CLL)‐reactive T‐cell lines and clones from HLA class I‐matched donors using modified B‐CLL cells as stimulators: implications for adoptive immunotherapy. Leukemia 2004; 18: 1278–87
  • Lee J. J., Choi B. H., Nam J. H., Park M. S., Song W. H., Yang D. H., et al. The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage. J Clin Apheresis 2004; 19: 130–6
  • Mayr C., Kofler D. M., Bunning H., Bund D., Hallek M., Wendtner C. M. Transduction of CLL cells by CD40 ligand enhances an antigen‐specific immune recognition by autologous T cells. Blood 2005; 106: 3223–6
  • Ghia P., Transidico P., Velga J. P., Schaniel C., Sallusto F., Matsushima K., et al. Chemoattractants MDC and TARC are secreted by malignant B‐cell precursors following CD40 ligation and support the migration of leukemia‐specific T cells. Blood 2001; 98: 533–40
  • Mohty M., Isnardon D., Charbonnier A., Lafage‐Pochitaloff M., Merlin M., Sainty D., et al. Generation of potent Th1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic cells. Int Immunol 2002; 14: 741–50
  • Kufner S., Fleischer R. P., Kroell T., Schmidt C., Ziztelsberger H., Salih H., et al. Serum‐free generation and quantification of functionally active leukemia‐derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes. Cancer Immunol Immunother 2005; 54: 953–70
  • Corcione A., Arduino N., Ferretti E., Pistorio A., Spinelli M., Ottonello L., et al. Chemokine receptor expression and function in childhood acute lymphoblastic leukemia of B‐lineage. Leuk Res 2006; 30: 365–72
  • Jongen‐Lavrencic M., Salesse S., Delwel R., Verfaillie C. M. BCR/ABL‐mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR/ABL‐positive cells. Leukemia 2005; 19: 373–80
  • Romano C., Fanis U. D., Sellitto A., Mora L. D., Chiurazzi F., Giunta R., et al. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells. Leuk Lymphoma 2003; 44: 1963–71
  • Rousseau R. F., Biagi E., Dutour A., Yvon E. S., Brown M. P., Lin T., et al. Immunotherapy of high‐risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL‐2 after chemotherapy and allogeneic stem cell transplantation. Blood 2006; 107: 1332–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.